Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (29 ops.)
Latest filing published 09 Dec 2025 for Akero Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleJonathan Young
Insider track record
Disclosed buys
0
Disclosed sells
29
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jonathan Young: trading record in brief
Jonathan Young (senior executive) discloses dealings in Akero Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 3 May 2021 to 9 December 2025, the count stands at 55 filings.
The open-market record consists of 29 sales worth €5.1M, with no purchase. The rest of the record consists of 6 share grants and 15 option exercises. 2025 to date brings no purchases and 7 sales.
The newest entry dates from 9 December 2025: a transaction, in Akero Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jonathan Young
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations55 total
152,616 sharesCommon StockSEC:0001193125-25-312092:0
20,000 sharesCommon StockSEC:0001193125-25-312092:1
20,000 sharesCommon StockSEC:0001193125-25-312092:2
20,000 sharesCommon StockSEC:0001193125-25-312092:3
47,573 sharesCommon StockSEC:0001193125-25-312092:4
4,284 shares@ US$21.091.0% of flowCommon StockSEC:0001193125-25-300488:0
12,500 shares@ US$21.102.8% of flowCommon StockSEC:0001193125-25-230294:0
586 shares@ US$43.020.3% of flowCommon StockSEC:0000950170-25-114666:0
12,500 shares@ US$21.103.0% of flowCommon StockSEC:0001779805-25-000007:0
12,500 shares@ US$21.103.0% of flowCommon StockSEC:0000950170-25-108234:0
890 shares@ US$23.8680.2% of flowCommon StockSEC:0000950170-25-093321:0
1,453 shares@ US$54.841.0% of flowCommon StockSEC:0000950170-25-088635:0
2,493 shares@ US$53.9931.7% of flowCommon StockSEC:0000950170-25-085667:0
607 shares@ US$44.880.3% of flowCommon StockSEC:0000950170-25-039745:0
11,447 shares@ US$44.1686.2% of flowCommon StockSEC:0000950170-25-033998:0
5,100 shares@ US$53.5653.4% of flowCommon StockSEC:0000950170-25-014188:0
43,064 shares@ US$6.3643.4% of flowCommon StockSEC:0000950170-25-009326:0
10,000 shares@ US$28.0333.5% of flowCommon StockSEC:0000950170-25-001850:0
24,300 shares0Common StockSEC:0000950170-24-138152:0
2,503 shares@ US$30.790.9% of flowCommon StockSEC:0000950170-24-136023:0
10,000 shares@ US$32.1313.9% of flowCommon StockSEC:0000950170-24-133434:0
15,481 shares@ US$32.2675.9% of flowCommon StockSEC:0000950170-24-121102:2
292 shares@ US$32.9370.1% of flowCommon StockSEC:0000950170-24-121102:3
40,716 shares@ US$21.0910.1% of flowCommon StockSEC:0000950170-24-121102:0
34,943 shares@ US$31.25412.8% of flowCommon StockSEC:0000950170-24-121102:1
25 of 55 declarations
